Dergiler / Turkish Journal of Medical Sciences / 2021 / Cilt: 51 - Sayı: 3

Evaluation of S100A12 protein levels in children with familial Mediterranean fever

Sayfa
1396–1405
Yayın Tarihi
2022-11-05
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

S100A12 level might be an important indicator in the monitoring of chronic inflammation in patients with FMF.Key words: Children, familial Mediterranean fever, inflammation, S100A12

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Background/aim: Familial Mediterranean fever (FMF), the most common autoinflammatory disease in children, is characterized by recurrent febrile episodes.
📊
Temel Bulgular & Veri:This study aimed to investigate the relationship of S100A12, an inflammatory marker, with attacks and inflammatory events in FMF patients.
💡
Sonuç & Katkı:S100A12 level might be an important indicator in the monitoring of chronic inflammation in patients with FMF.Key words: Children, familial Mediterranean fever, inflammation, S100A12
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Background/aim: Familial Mediterranean fever (FMF), the most common autoinflammatory disease in children, is characterized by recurrent febrile episodes. FMF is known to progress with chronic inflammation, particularly during attack periods. This study aimed to investigate the relationship of S100A12, an inflammatory marker, with attacks and inflammatory events in FMF patients. Materials and methods: The study included 57 patients diagnosed with FMF, 43 in an attack-free period and 14 in an attack period, and 31 healthy children as the control group. Only white blood cell (WBC) count, C-reactive protein (CRP) level, erythrocyte sedimentation rate (ESR), and S100A12 level were analyzed in the control group. In addition, serum amyloid A (SAA), and fibrinogen levels were measured, and a mutation analysis was performed in the patient group. The results were compared among the attack-free period, acute attack FMF and control groups. Results: The mean age of patients and control group was 10 (2.5–18) and 9.5 (2.5–16) years, respectively. The CRP (p = 0.001), S100A12 (p = 0.003) and ESR (p= 0.001) values differed significantly between the FMF and control groups. S100A12 level (p = 0.027), WBC count (p = 0.003), CRP level (p = 0.0001), ESR (p = 0.004), and fibrinogen level (p = 0.001) differed significantly between the acute attack and attack-free period groups. SAA level (p = 0.05), ESR (p = 0.001), fibrinogen level (p = 0.001), WBC count (p = 0.001), and S100A12 level (p = 0.027) were higher in M694V homozygous FMF patients than in other FMF patients. Conclusion: Patients with FMF had higher S100A12 levels than the control group, while the mean S100A12 concentration was higher in acute attack period patients than in attack-free period patients. S100A12 level might be an important indicator in the monitoring of chronic inflammation in patients with FMF.Key words: Children, familial Mediterranean fever, inflammation, S100A12

🔖

Bu Makaleye Atıf Yap

TÜRKMENOĞLU, Y., DURSUN, H., İRDEM, A., BEZEN, D., ERTÜRK, B., GÜNEY, E. (2022). Evaluation of S100A12 protein levels in children with familial Mediterranean fever. Turkish Journal of Medical Sciences, Cilt: 51 - Sayı: 3, 1396–1405. https://ajindex.com/articles/609496

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Ben-Chetrit and Levy. Familial Mediterranean fever. Lancet 1998
  2. 351 (9103): 659-664. doi: 10.1016/S0140-6736(97)09408-7 2. Ozen S, Demirkaya E, Erer B, Livneh A, Ben-Chetrit E et al. EULAR recommendations for the management of familial Mediterranean fever. Annals of the Rheumatic Diseases 2016
  3. 75 (4): 644-651. doi: 10.1136/annrheumdis-2015-208690 3. Barut K, Sahin S, Adrovic A, Sinoplu AB, Yucel G et al. Familial Mediterranean fever in childhood: a single-center experience. Rheumatology International 2018
  4. 38 (1): 67-74. doi: 10.1007/ s00296-017-3796-0 4. Yilmaz E, Ozen S, Balci B, Duzova A, Topaloglu R et al. Mutation frequency of familial Mediterranean fever and evidence for a high carrier rate in the Turkish population. European Journal of Human Genetics 2001
  5. 9 (7): 553-555. doi: 10.1038/sj.ejhg.5200674 5. Pras E, Aksentijevich I, Gruberg L, Balow JE, Prosen L et al. Mapping of a gene causing familial Mediterranean fever to the short arm of chromosome 16. New England Journal of Medicine 1992
  6. 326 (23): 1509-1513. doi.org/10.1056/ NEJM199206043262301 6. Tanatar A, Karadağ ŞG, Çakan M, Sönmez HE, Ayaz NA. Age of onset as an influencing factor for disease severity in children with familial Mediterranean fever. Modern Rheumatology 2021
  7. 31 (1): 219-222. doi: 10.1080/14397595.2020.1719594 7. Chae JJ, Komarow HD, Cheng J, Wood G, Raben N et al. Targeted disruption of pyrin, the FMF protein, causes heightened sensitivity to endotoxin and a defect in macrophage apoptosis. Molecular Cell 2003
  8. 11 (3): 591-604. doi: 10.1016/s1097-2765(03)00056-x 8. Dinarello CA. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 2011
  9. 117 (14): 3720-3732. doi: 10.1182/blood-2010-07-273417 9. Holzinger D, Foell D, Kessel C. The role of S100 proteins in the pathogenesis and monitoring of autoinflammatory diseases. Molecular and Cellular Pediatrics 2018
  10. doi:10.1186/s40348- 018-0085-2 10. Šumová B, Cerezo LA, Szczuková L, Nekvindová L, Uher M et al. Circulating S100 proteins effectively discriminate SLE patients from healthy controls: a cross-sectional study. Rheumatology International 2019
  11. 39 (3): 469-478. doi: 10.1007/s00296-018- 4190-2 11. Brown KL, Lubieniecka JM, Armaroli G, Kessel K, Gibson KM et al. S100A12 Serum levels and PMN counts are elevated in childhood systemic vasculitis especially involving proteinase 3 specific anti-neutrophil cytoplasmic antibodies. Frontiers in Pediatrics 2018
  12. 23 (6): 341. doi: 10.3389/fped.2018.00341 12